1. Home
  2. DMO vs RANI Comparison

DMO vs RANI Comparison

Compare DMO & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Mortgage Opportunity Fund Inc.

DMO

Western Asset Mortgage Opportunity Fund Inc.

HOLD

Current Price

$9.77

Market Cap

116.9M

Sector

Finance

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.80

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMO
RANI
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.9M
106.9M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
DMO
RANI
Price
$9.77
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
45.6K
474.9K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
N/A
N/A
Revenue
N/A
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
58.85
52 Week Low
$9.73
$0.45
52 Week High
$12.08
$3.87

Technical Indicators

Market Signals
Indicator
DMO
RANI
Relative Strength Index (RSI) 22.69 47.91
Support Level N/A $0.73
Resistance Level $11.20 $0.83
Average True Range (ATR) 0.11 0.05
MACD -0.02 -0.00
Stochastic Oscillator 7.05 45.20

Price Performance

Historical Comparison
DMO
RANI

About DMO Western Asset Mortgage Opportunity Fund Inc.

Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: